IDP.L

InnovaDerma Plc
InnovaDerma PLC - Result of AGM
27th January 2022, 16:10
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8984Z
InnovaDerma PLC
27 January 2022
 

 

 LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Results of Annual General Meeting

InnovaDerma (LSE: IDP), a leading digitally focused UK beauty brand developer, is pleased to announce that at its Annual General Meeting ("AGM") held earlier today, all resolutions, were duly passed on a poll. 

AGM Resolutions

Resolutions 12 and 13 were proposed as special resolutions. All other resolutions were proposed as ordinary resolutions.  The results of the poll are set out below: 

Issued Share Capital ("ISC")

28,057,825

Votes cast (average across all resolutions)

1,824,040

% of ISC voted (average across all resolutions)

6.5%

 

RESOLUTIONS

Votes For

%

Votes Against

%

Votes Cast

Vote withheld*

% of ISC voted

1. To receive and adopt the annual accounts for the year ended 30 June 2021.

1824195

100%

0

0%

1824195

29919

6.5%

 

 

 

2. To receive and approve the director's remuneration report for the year ended 30 June 2021.

1816581

99.6%

7464

0.4%

1824045

30069

6.5%

 

 

 

3. To approve the Directors' Remuneration Policy

1816581

99.6%

7464

0.4%

1824045

30069

6.5%

 

 

4. To reappoint Crowe UK LLP as auditors of the company.

1816731

99.7%

5861

0.3%

1822592

31522

6.5%

 

 

5. To authorise the directors to fix the remuneration of the auditors.

1824195

100%

0

0%

1824195

29919

6.5%

 

 

6. To reappoint Ross Andrews as a director.

1806314

99.1%

16278

0.9%

1822592

31522

6.5%

 

7. To reappoint Mark Michael Ward as a director.

1818186

100%

0

0%

1818186

35928

6.5%

 

 

8. To reappoint Andrew Dunderdale as a director.

1817314

99.7%

5278

0.3%

1822592

31522

6.5%

 

 

9. To reappoint Blake Hughes as a director.

1812908

99.7%

5278

0.3%

1818186

35928

6.5%

 

10. To reappoint Simon Pyper as a director.

1817314

99.7%

5278

0.3%

1822592

31522

6.5%

 

11. To confer on the Directors authority to allot securities in accordance with Section 551 of the Companies Act 2006.

1809509

99.3%

13083

0.7%

1822592

31522

6.5%

 

 

 

 

12. To confer on the Directors power to allot securities under a disapplication of Section 561 of the Companies Act 2006.

1805103

99.3%

13083

0.7%

1818186

35928

6.5%

 

 

 

 

13. To authorise the Company to make market purchases of its own shares for the purposes of Sections 693 and 701 of the Companies Act 2006.

1811695

98%

36825

2%

1848520

5594

6.6%

 

 

 

 

* A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes 'For' or 'Against' a resolution.

The full text of all the resolutions can be found in the Notice of Annual General Meeting which is available for viewing from the Group's website at:  https://www.innovaderma.com/company-publications

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

InnovaDerma

Blake Hughes

 

c/o TB Cardew

finncap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew


Shan Shan Willenbrock/

+ 44 (0)7775 848537

Olivia Rosser

+ 44 (0)7552 864250


innovaDerma@tbcardew.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPPUMUGUPPGQM ]]>
TwitterFacebookLinkedIn